Medicinal Surface Modification of Silicon Nanowires: Impact on Calcification and Stromal Cell Proliferation
Source abstract
Abstract
Medicinal surface modification of silicon nanowires (SiNWs) with selected bisphosphonates, such as the known antiosteoporotic drug alendronate, is described. In terms of specific assays relevant to orthopedic applications, the impact of selected bisphosphonate attachment on acellular calcification in simulated plasma is reported. To further investigate biocompatibility, proliferation assays of these modified nanowires were carried out using an orthopedically relevant cell line: mesenchymal stem cells derived from mouse stroma. It is found that the identity of the bisphosphonate ligand strongly and sensitively impacts its resultant cytotoxicity.
Source: openalex_inverted_index · Quality: baseline
Research context
OpenAlex topics: Graphene and Nanomaterials Applications · Bone Tissue Engineering Materials · Nanowire Synthesis and Applications
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Department of Chemistry and Department of Biology, Texas Christian University, Fort Worth, Texas 76129
References (29)
Show source-provided references
1. Xia Y. · Adv. Mater. · 2003 · 15 · 35310.1002/adma.200390087 ↗
2. Gudiksen M. S. · Nature · 2002 · 415 · 61710.1038/415617a ↗
3. Cui Y. · Science · 2001 · 293 · 128910.1126/science.1062711 ↗
4. Cui Y. · Science · 2001 · 291 · 891
5. Huang Y. · Science · 2001 · 291 · 63010.1126/science.291.5504.630 ↗
6. Huang Y. · Science · 2001 · 294 · 131310.1126/science.1066192 ↗
7. Patolsky F. · Proc. Natl. Acad. Sci. · 2004 · 101 · 1401710.1073/pnas.0406159101 ↗
8. Patolsky F. · Science · 2006 · 313 · 110010.1126/science.1128640 ↗
9. Canham L. T. · Adv. Mater. · 1996 · 8 · 84710.1002/adma.19960081019 ↗
10. Canham L. T. · Adv. Mater. · 1995 · 7 · 103310.1002/adma.19950071215 ↗
11. Canham L. T. · Adv. Mater. · 1996 · 8 · 85010.1002/adma.19960081020 ↗
12. Nagesha D. K. · Adv. Mater. · 2005 · 17 · 92110.1002/adma.200401362 ↗
13. Kim W. · J. Am. Chem. Soc. · 2007 · 129 · 722810.1021/ja071456k ↗
14. Qi S. · ChemBioChem · 2007 · 8 · 111510.1002/cbic.200700119 ↗
15. Yi C. · ChemBioChem · 2007 · 8 · 122510.1002/cbic.200700136 ↗
16. Fleisch H. · Osteroporosis Int. · 1993 · 3 · 1510.1007/BF01623222 ↗
17. Coleman R. E. · Cancer Treat. Rev. · 2001 · 27 · 16510.1053/ctrv.2000.0210 ↗
18. Roux C. · Drugs · 1999 · 58 · 82310.2165/00003495-199958050-00005 ↗
19. Delmas P. D. · Lancet · 2002 · 359 · 201810.1016/S0140-6736(02)08827-X ↗
20. Ito M. · Calcif. Tissue. Int. · 1998 · 63 · 14310.1007/s002239900505 ↗
21. Rogers M. J. · Cancer · 2000 · 88 · 296110.1002/1097-0142(20000615)88:12+<2961::AID-CNCR12>3.0.CO;2-L ↗
22. Senzaki H. · Urol. Res. · 2004 · 32 · 22310.1007/s00240-004-0409-7 ↗
23. Virtanen S. S. · Cancer Res. · 2002 · 62 · 2708
24. Giuliani N. · Bone · 1998 · 22 · 45510.1016/S8756-3282(98)00033-7 ↗
25. Kokubo T. · J. Biomed. Mater. Res. · 1990 · 24 · 72110.1002/jbm.820240607 ↗
26. Rodan G. A. · Ann. Med. · 1993 · 25 · 37310.3109/07853899309147299 ↗
27. Whitehead M. A. · Tissue Eng. A · 2008 · 14 · 19510.1089/ten.a.2006.0370 ↗
28. Tuan R. S. · Arthritis Res. Ther. · 2003 · 5 · 3210.1186/ar614 ↗
29. Bodde E. W. H. · Tissue Eng. A · 2008 · 14 · 29